Market Place
Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most! 
X
Please Wait
Applying Filters...
01 Evonik Operations GmbH (1)
02 AURORE PHARMACEUTICALS PRIVATE LIMITED (2)
03 Aurobindo Pharma Limited (1)
04 Cambrex Charles City, Inc. (1)
05 Cipla Ltd. (1)
06 Dasami Lab Private Limited (1)
07 Esteve Huayi Pharmaceuticals Co., Ltd (1)
08 Hetero Labs Limited (4)
09 Honour Lab Limited (1)
10 Laurus Labs Limited (2)
11 MYLAN LABORATORIES LIMITED (2)
12 Macleods Pharmaceuticals Limited (1)
13 Mylan Laboratories Limited (1)
14 Uquifa Spain (1)
15 Yuhan Chemical Inc. (1)
01 EMTRICITABINE (3)
02 Emtricitabine (14)
03 Emtricitabine (Process -II) (1)
04 GS-9036 (1)
05 emtricitabine (2)
01 China (1)
02 Germany (1)
03 India (13)
04 South Korea (1)
05 Spain (1)
06 U.S.A (4)
77
PharmaCompass offers a list of Emtricitabine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Emtricitabine manufacturer or Emtricitabine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Emtricitabine manufacturer or Emtricitabine supplier.
PharmaCompass also assists you with knowing the Emtricitabine API Price utilized in the formulation of products. Emtricitabine API Price is not always fixed or binding as the Emtricitabine Price is obtained through a variety of data sources. The Emtricitabine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine, including repackagers and relabelers. The FDA regulates 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine supplier is an individual or a company that provides 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine active pharmaceutical ingredient (API) or 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine finished formulations upon request. The 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine suppliers may include 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine API manufacturers, exporters, distributors and traders.
click here to find a list of 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine suppliers with NDC on PharmaCompass.
We have 14 companies offering 1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine
Get in contact with the supplier of your choice:
